comparemela.com

Latest Breaking News On - ராணி சதுரம் நிறுவனம் ஆஃப் நரம்பியல் - Page 7 : comparemela.com

ISMRM Awards Gold Medals At Annual Meeting And Announces New President

ISMRM Awards Gold Medals At Annual Meeting And Announces New President

ISMRM Awards Gold Medals At Annual Meeting And Announces New President
cataniaoggi.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cataniaoggi.it Daily Mail and Mail on Sunday newspapers.

CurePSP awards three new Venture Grants for the study of PSP and CBD

CurePSP awards three new Venture Grants for the study of PSP and CBD Studies will focus on toxic protein in the brain and genetic factors News provided by Share this article Share this article NEW YORK, April 15, 2021 /PRNewswire/  CurePSP has awarded Venture Grants to three researchers studying tau protein pathology and genetic factors in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). Each grant is for $100,000. Dr. Rohan de Silva of UCL Queen Square Institute of Neurology in London has received a grant for his study of the propagation of toxic tau protein in the brain. The aim of this project is to understand how healthy tau is converted to toxic strains related to PSP and CBD and to identify their imprinted defects that enable the strain-specific progression. As Dr. de Silva explains, Tau protein is essential for healthy nerve cells, but tau gone bad drives the devastating damage and progression of PSP, CBD, and other diseases involving the tau

AI Identifies New Multiple Sclerosis Subtypes from Brain Scans

AI Identifies New Multiple Sclerosis Subtypes from Brain Scans In MS, the central nervous system is attacked, damaging the myelin covers of nerve cells. [© iceteastock - Fotolia.com] April 8, 2021 Scientists at University College London (UCL) have used artificial intelligence (AI) to identify three new multiple sclerosis (MS) subtypes from brain MRI scans. The researchers say the findings will help to identify those individuals with MS who are more likely to have disease progression, and could aid in more effective treatment targeting. Arman Eshaghi, MD, PhD, at UCL Queen Square Institute of Neurology, explained, “Currently MS is classified broadly into progressive and relapsing groups, which are based on patient symptoms; it does not directly rely on the underlying biology of the disease, and therefore cannot assist doctors in choosing the right treatment for the right patients. Here, we used artificial intelligence and asked the question: can AI find MS subtypes that follow a

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.